Impact of the COVID-19 pandemic in patients with a previous history of premature myocardial infarction

Kayıkçıoğlu, Meral; Tunçel, Özlem Kuman; Tokgözoğlu, Lâle

doi:10.1016/j.ajpc.2020.100128

Cited by 10 publications

(7 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Disease burden of COVID-19 negatively impacted health care providers, hospital facilities and even drug and medical equipment supply. On the other hand, social restrictions, lockdown policies and the concerns of patients resulted in a deterioration in the courses of several chronic diseases [7][8][9][10]. As DM is one of the leading chronic diseases, current study aimed to evaluate the effect of COVID-19 pandemic on the course of DM in patients without a COVID-19 history at any time.…”

Section: Discussionmentioning

confidence: 99%

The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli

Selek

Gezer

Altun³

et al. 2021

J Diabetes Metab Disord

View full text Add to dashboard Cite

Aims The aim of this study is to determine the impact of the COVID-19 pandemic on the management and disease control of the patients with diabetes mellitus in Kocaeli. Methods This study was carried out in six leading central hospitals in five major districts of Kocaeli. The study was conducted between June 2020 and November 2020. The patients who had previous admissions to these clinics within 6 months prior to the pandemic were enrolled in the study. Results A total of 283 patients were enrolled in the study, among them 151 (53%) patients were female, 268 (95%) had type 2 DM and remaining 5% had type 1 DM. The median weight of the patients was similar between the previous and last visits (84 kg vs 83 kg, p = 0,88). Laboratory parameters of previous and current visits revealed that mean fasting plasma glucose (FPG) and HbA1c levels were not significantly changed. The number of the patients who had controlled blood pressure was significantly decreased. The number of those who had neuropathic complains and the severity of dyslipidemia significantly increased during pandemic period. Conclusion Our study demonstrated that despite decreased compliance with diet and exercise, and difficulty in accessing medication, there was no significant change in weight, FPG and HbA1c levels in diabetic patients. Since cultural differences, education level and socioeconomic opportunities differ between societies, national and international studies will be more accurate to evaluate the effects of epidemics on the course of chronic diseases.

show abstract

Section: Discussionmentioning

confidence: 99%

The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli

Selek

Gezer

Altun³

et al. 2021

J Diabetes Metab Disord

View full text Add to dashboard Cite

show abstract

“…The above circumstances contributed to delays in diagnosis, management, or treatment of disease to some extent ( de Joode et al, 2020 ; Jazieh et al, 2020 ; Breast Screening Working Group (WG2) of the Covid-19 and Cancer Global Modelling Consortium et al, 2021 ). Patients with chronic diseases such as hypertension, dyslipidemia, diabetes, cerebrovascular disease, heart disease, or cancer–collectively referred to as patients with underlying medical conditions, who have a higher risk of developing serious illness due to COVID-19 ( Aggarwal et al, 2020 ; Dai et al, 2020 ; Liang et al, 2020 ; Zhou et al, 2020 ; Centers for Disease Control and Prevention, 2022c ) might experience psychological burden ( de Joode et al, 2020 ; Kayikcioglu et al, 2020 ; Wang Y. et al, 2020 ; Kim and Kim, 2022a , c ; Ozkan et al, 2022 ). For example, a retrospective study in the UK analyzed the impact of COVID-19 on patient-reported health outcomes at a 30-day follow-up after hospitalization for acute stroke ( Ozkan et al, 2022 ).…”

Section: Introductionmentioning

confidence: 99%

Health-related quality of life and depressive symptoms of patients with chronic diseases and the general population before and during the COVID-19 pandemic in Korea

Park

2023

Front. Psychol.

View full text Add to dashboard Cite

ObjectiveThe unprecedented coronavirus disease 2019 (COVID-19) outbreak has resulted in a global crisis that negatively impacted physical well-being and mental health. Our goal was to investigate the impact of the COVID-19 pandemic on health-related quality of life (HRQoL) and depressive symptoms in patients with chronic diseases and the general population in Korea.MethodsData from 8341 patients with chronic diseases and 12,395 general population aged ≥20 years who participated in the Korea National Health and Nutrition Examination Survey (2017–2020) were analyzed. Patients with hypertension, dyslipidemia, diabetes, cerebrovascular disease (stroke), heart disease (myocardial infarction or angina pectoris), or cancer were classified as patients with chronic diseases. The general population was defined as those not suffering from corresponding chronic diseases. A modified EuroQol-5 Dimensions (EQ-5D), with three levels (0: extreme problems; 0.5: some problems; 1: no problems) for each dimension in EQ-5D, was used to assess HRQoL. To analyze depressive symptoms among patients with chronic diseases and the general population, we used the Patient Health Questionnaire-9 (PHQ-9) and defined a PHQ-9 score ≥ 10 as having a depressive symptom. Multivariate linear and logistic regression analyses were used to analyze HRQoL and depressive symptoms before and during the COVID-19 pandemic.ResultsThe HRQoL level was significantly lower in patients with chronic diseases compared to the general population on all dimensions both before and during the COVID-19 pandemic (all value of p < 0.05). Patients with chronic diseases had significantly lower HRQoL levels associated with the anxiety/depression dimension during the COVID-19 pandemic than in the pre-pandemic period (0.940 ± 0.002 vs. 0.929 ± 0.004, value of p = 0.041). In addition, patients with chronic diseases were more likely to report depressive symptoms during the COVID-19 pandemic than in the pre-pandemic period (Odds ratio (OR): 1.755, 95% confidence interval (CI): 1.209–2.546, value of p = 0.003). However, this association was not observed in the general population (OR: 1.275, 95% CI: 0.933–1.742, value of p = 0.13).ConclusionThe COVID-19 pandemic affected the HRQoL and psychological health in patients with chronic diseases with higher anxiety/depression during the pandemic than in the pre-pandemic period. These results suggest that it is urgent to establish continuous management guidelines, including psychosocial management for high-risk groups, and to improve the existing healthcare system.

show abstract

“…The current pandemic has hampered the preventive efforts with less patients seeking medical care [ [47] , [48] , [49] ]. However, important precautions have been taken to avoid unnecessary visits to hospitals and to prevent disruption of chronic treatments; enabling patients to access drugs for chronic diseases from pharmacies without new prescriptions during the pandemic.…”

Section: Structure Of Healthcare and Modifications In The Health Care System For Cardiovascular Preventionmentioning

confidence: 99%

The landscape of preventive cardiology in Turkey: Challenges and successes

Tokgözoğlu

Kayıkçıoğlu

Ekinci

2021

American Journal of Preventive Cardiology

Self Cite

View full text Add to dashboard Cite

Turkey, like many countries, is facing a growing burden of non-communicable disease (NCD)s and is among the countries with high cardiovascular mortality in Europe. Moreover, Turkey currently has the highest rate of premature cardiovascular disease (CVD) in Europe. During the last decades, Turkey made fundamental reforms in the health system to improve the treatment of risk factors to prevent CVD. The most outstanding success was in the area of tobacco control (13.4% decrease in smoking prevalence) and decreasing the salt consumption of the population (from 18 to 9.9 g/day) leading to a significant decrease in CVD mortality from 45% to 36.8% of all deaths. However, obesity and diabetes are increasing rapidly as a result of urbanization, low physical activity and unhealthy eating and the new generation is starting to take up smoking. The increase in cardiometabolic risk factors and aging of the population are expected to increase the number of CVD deaths. All CVD risk factors except smoking are significantly more prevalent in women. In addition, rare disease is a country specific problem with a significant contribution to the high rates of premature CVD in Turkey. Despite major improvements in management in acute coronary syndromes, sustained achievement in guideline recommended goals is suboptimal. In patients with a previous cardiovascular event smoking rate is 25.5%, 80.9% of these patients are overweight (BMI ≥25 kg/m 2 ), 30% obese (BMI ≥30 kg/m 2 ), and LDL‐cholesterol targets of 70 mg/dL are attained in only 18%. Herein, we scrutinize the achievements and challenges of Turkey in establishing a ‘National Heart Health Policy’ aiming to decrease the burden of CVD and its risk factors.

show abstract

Impact of the COVID-19 pandemic in patients with a previous history of premature myocardial infarction

Cited by 10 publications

References 22 publications

The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli

The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli

Health-related quality of life and depressive symptoms of patients with chronic diseases and the general population before and during the COVID-19 pandemic in Korea

The landscape of preventive cardiology in Turkey: Challenges and successes

Contact Info

Product

Resources

About